HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Artio Medical Closes Tranche of $12 Million in Series A Financing
Company to accelerate clinical testing and prepare for commercialization of its broad portfolio of products.
Kaia Health Raises $75 Million Series C to Optimize MSK and COPD Care in the U.S. and Europe
The investment will grow its commercial team and accelerate product and partnership development to help more Americans access Kaia Health MSK solution and expand the offering to COPD care.
XENOCOR Secures Investment from Growing Impact Ventures
Announces a series A-2 round investment by Growing Impact Ventures to enable increased production in response to growing market demand for the Xenoscope™, the first single–use, fog-free, HD laparoscopic imaging system.
Glytec Raises $21 Million
Funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department.
Ronovo Surgical Completes Series A Financing
Ronovo was founded in Shanghai in 2019 to establish a transformative technology platform that democratizes MIS and digital surgery in the vastly underserved Chinese surgical market.
ONWARD Completes $32 Million Financing Round
Proceeds from the financing will be used to fund the continued development and commercialization of ONWARD’s ARC Therapy.
Proximie Raises $38m Series B Funding To Accelerate Its Expansion in U.S. and European Markets
F-Prime Capital led financing, joined by Questa Capital, Eight Roads, and Maverick Ventures
FemTech Leader Willow ® Adds Diverse Set Of Investors In Extended Series C Round
Willow notes an additional $26.8 Million in funding through a Series C Extension round, led by Endeavour Vision, alongside New Enterprise Associates, Pura Vida Investments, Purple Arch Ventures, Logos Capital, and Gaingels.
Tempo Raises $220M in New Capital to Enhance AI & 3D Sensor Technology
The Series C round was led by SoftBank Vision Fund 2* with participation from new investor Steadfast Capital Ventures, and returning investors DCM, General Catalyst, Norwest Venture Partners, and Bling Capital.
